MedCap AB (MCAP) Stock Statistics & Valuation Metrics

MedCap AB has a market cap or net worth of kr8.22B. The enterprise value is kr7.30B.

MedCap AB has 15,080,753 shares outstanding. The number of shares has decreased by -2.65% in one year.

MedCap AB’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 10.35%.

The current PE Ratio of MedCap AB is 36.4. MedCap AB’s PEG ratio is 7.70.

In the last 12 months, MedCap AB had revenue of 2.11B and earned 219.80M in profits. Earnings per share was 14.67.

In the last 12 months, operating cash flow was 338.90M and capital expenditures -44.30M, giving a free cash flow of 294.60M billion.

MedCap AB pays an annual dividend of ―, resulting in a dividend yield of ―

MedCap AB upcoming earnings date is Jul 21, 2026, TBA (Confirmed).

MedCap AB as a current ratio of 2.01, with Debt / Equity ratio of 31.34%

In the past 12 months, MedCap AB has paid 68.30M in taxes.

MedCap AB EV to EBITDA ratio is 17.60, with an EV/FCF ratio of 29.73.

MedCap AB has kr394.40M in cash and marketable securities with kr478.10M in debt, giving a net cash position of -kr83.70M billion.

Gross margin is 37.23%, with operating margin of 14.24%, and net profit margin of 10.43%.

The average price target for MedCap AB is ―, which is 11.43% higher than the current price. The consensus rating is ―